News
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
Food and Drug Administration (FDA) Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding the abortion drug, mifepristone, ...
Whether your snoring originates from your throat or nose, the best anti-snore devices can help open airways or adjust your ...
Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...
Kratom-based products have exploded in popularity in recent years despite a lack of FDA approval. Did a Myrtle Beach supplier ...
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
Explore more
TransMedics surpasses Q1 2025 estimates, raises guidance, and shows strong growth. Click to read more on why I see TMDX as an ...
Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...
The U.S. drug regulator said on Friday a unit of Johnson & Johnson issued a correction for certain lots of a part related to ...
On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...
Verastem Oncology's VS-7375 receives FDA fast track designation, offering hope for targeted treatment in KRAS G12D-mutated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results